Taiwan
· Delayed Price · Currency is TWD Orient EuroPharma Statistics
Total Valuation
TPEX:4120 has a market cap or net worth of TWD 4.34 billion. The enterprise value is 7.75 billion.
| Market Cap | 4.34B |
| Enterprise Value | 7.75B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4120 has 86.75 million shares outstanding. The number of shares has decreased by -0.10% in one year.
| Current Share Class | 86.75M |
| Shares Outstanding | 86.75M |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 13.62% |
| Owned by Institutions (%) | 1.38% |
| Float | 32.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.98 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 126.21, with an EV/FCF ratio of -63.46.
| EV / Earnings | -22.29 |
| EV / Sales | 1.74 |
| EV / EBITDA | 126.21 |
| EV / EBIT | n/a |
| EV / FCF | -63.46 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.11 |
| Quick Ratio | 0.70 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 38.22 |
| Debt / FCF | -34.01 |
| Interest Coverage | -0.90 |
Financial Efficiency
Return on equity (ROE) is -5.54% and return on invested capital (ROIC) is -0.60%.
| Return on Equity (ROE) | -5.54% |
| Return on Assets (ROA) | -0.52% |
| Return on Invested Capital (ROIC) | -0.60% |
| Return on Capital Employed (ROCE) | -1.10% |
| Revenue Per Employee | 13.11M |
| Profits Per Employee | -1.03M |
| Employee Count | 339 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, TPEX:4120 has paid 116.63 million in taxes.
| Income Tax | 116.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.10% in the last 52 weeks. The beta is 0.19, so TPEX:4120's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +17.10% |
| 50-Day Moving Average | 46.83 |
| 200-Day Moving Average | 48.85 |
| Relative Strength Index (RSI) | 66.02 |
| Average Volume (20 Days) | 27,027 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4120 had revenue of TWD 4.44 billion and -347.80 million in losses. Loss per share was -4.01.
| Revenue | 4.44B |
| Gross Profit | 2.10B |
| Operating Income | -93.73M |
| Pretax Income | -176.33M |
| Net Income | -347.80M |
| EBITDA | 62.80M |
| EBIT | -93.73M |
| Loss Per Share | -4.01 |
Balance Sheet
The company has 1.42 billion in cash and 4.15 billion in debt, giving a net cash position of -2.73 billion or -31.48 per share.
| Cash & Cash Equivalents | 1.42B |
| Total Debt | 4.15B |
| Net Cash | -2.73B |
| Net Cash Per Share | -31.48 |
| Equity (Book Value) | 6.19B |
| Book Value Per Share | 63.48 |
| Working Capital | 362.46M |
Cash Flow
In the last 12 months, operating cash flow was -23.40 million and capital expenditures -98.75 million, giving a free cash flow of -122.15 million.
| Operating Cash Flow | -23.40M |
| Capital Expenditures | -98.75M |
| Free Cash Flow | -122.15M |
| FCF Per Share | -1.41 |
Margins
Gross margin is 47.16%, with operating and profit margins of -2.11% and -7.83%.
| Gross Margin | 47.16% |
| Operating Margin | -2.11% |
| Pretax Margin | -3.97% |
| Profit Margin | -7.83% |
| EBITDA Margin | 1.41% |
| EBIT Margin | -2.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.10% |
| Shareholder Yield | 2.12% |
| Earnings Yield | -8.02% |
| FCF Yield | -2.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.
| Last Split Date | Jul 28, 2010 |
| Split Type | Forward |
| Split Ratio | 1.16 |
Scores
TPEX:4120 has an Altman Z-Score of 1.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.08 |
| Piotroski F-Score | 3 |